Skip to main content
OpenTrials

Clinical trial condition

Thoracic Neoplasms

Explore clinical trials studying Thoracic Neoplasms. Study availability and eligibility vary by location and protocol.

8,100 public trials 1,857 recruiting studies
Refine in advanced search Browse all conditions

Thoracic Neoplasms trial results

Completed

Study of Capmatinib and Spartalizumab Combination Therapy vs Docetaxel in Non-small Cell Lung Cancer

NCT03647488

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Grenoble, France
  • Novartis Investigative Site Lille Cédex, France
View Trial Details
Completed

A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)

NCT03322566

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Southern Cancer Center, PC Daphne, Alabama, United States
  • Western Regional Medical Center, Inc. Goodyear, Arizona, United States
  • Arizona Oncology Associates PC- HOPE Tucson, Arizona, United States
  • Lynn Cancer Institute Boca Raton, Florida, United States
View all 94 locations
View Trial Details
Completed

Hippocampus Avoidance PCI vs PCI

NCT01780675

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +9 more
Locations
  • Universitair Ziekenhuis Antwerpen Antwerp, Belgium
  • Universitair Ziekenhuis Gent Ghent, Belgium
  • Universitair Ziekenhuis Leuven Leuven, Belgium
  • The Netherlands Cancer Institute Amsterdam, Netherlands
View Trial Details
Completed

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

NCT00982111

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Nyack, New York, United States
  • ImClone Investigational Site Kogarah, New South Wales, Australia
  • ImClone Investigational Site Hobart, Tasmania, Australia
  • ImClone Investigational Site East Bentleigh, Victoria, Australia
View all 101 locations
View Trial Details
Completed

A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)

NCT03353675

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Charlotte Charlotte, North Carolina, United States
  • Nashville Nashville, Tennessee, United States
  • Libramont Libramont, Belgium
  • Créteil Créteil, France
View Trial Details

Related conditions